Primary Citation of Related Structures:   1JS3, 1JS6
PubMed Abstract: 
DOPA decarboxylase (DDC) is responsible for the synthesis of the key neurotransmitters dopamine and serotonin via decarboxylation of L-3,4-dihydroxyphenylalanine (L-DOPA) and L-5-hydroxytryptophan, respectively. DDC has been implicated in a number of clinic disorders, including Parkinson's disease and hypertension ...
DOPA decarboxylase (DDC) is responsible for the synthesis of the key neurotransmitters dopamine and serotonin via decarboxylation of L-3,4-dihydroxyphenylalanine (L-DOPA) and L-5-hydroxytryptophan, respectively. DDC has been implicated in a number of clinic disorders, including Parkinson's disease and hypertension. Peripheral inhibitors of DDC are currently used to treat these diseases. We present the crystal structures of ligand-free DDC and its complex with the anti-Parkinson drug carbiDOPA. The inhibitor is bound to the enzyme by forming a hydrazone linkage with the cofactor, and its catechol ring is deeply buried in the active site cleft. The structures provide the molecular basis for the development of new inhibitors of DDC with better pharmacological characteristics.
Related Citations: 
Preliminary X-ray analysis of a new crystal form of pig kidney DOPA decarboxylase Malashkevich, V.N., Burkhard, P., Dominici, P., Moore, P.S., Borri-Voltattorni, C., Jansonius, J.N. (1999) Acta Crystallogr D Biol Crystallogr 55: 568
Crystallization and preliminary X-ray analysis of pig kidney DOPA decarboxylase Malashkevich, V.N., Filipponi, P., Sauder, U., Dominici, P., Jansonius, J.N., Borri-Voltattorni, C. (1992) J Mol Biol 224: 1167
Organizational Affiliation: 
M.E. Müller Institute for Structural Biology, Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland. Peter.Burkhard@unibas.ch